Oncobiologics - 53 Year Dividend History | OTLK

Historical dividend payout and yield for Oncobiologics (OTLK) since 1971. The current TTM dividend payout for Oncobiologics (OTLK) as of May 24, 2024 is $0.00. The current dividend yield for Oncobiologics as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.185B $0.000B
Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.
Stock Name Country Market Cap PE Ratio